Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product ...

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agree ...
Santé log

Ascendis Pharma Reports Third Quarter 2025 Financial Results

For the third quarter of 2025, Ascendis Pharma reported a net loss of €61.0 million, or €1.00 per share basic and diluted compared to a net loss of €99.2 million, or €1.72 per share basic and diluted ...
Le Lézard

Savara Reports Third Quarter 2025 Financial Results and Provides Business Update

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025. "Our recent ...

Nurexone Secures Over C$3.18 Million Through Accelerated Warrant Exercises

Nurexone Secures Over C$3.18 Million Through Accelerated Warrant Exercises. NurExone Honored at Berlin and Stockholm Conferences for Breakthrough Contributions to Global Life Sciences and Health ...